Scott Mendel
CIK: 0001515051
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Oct 1, 2026QTRX
Quanterix Corp
Award(A)Direct4.4K shares at avg. $3.41$15K - Jul 8, 2026QTRX
Quanterix Corp
Exercise(M)Direct8.1K shares- - Jul 1, 2026QTRX
Quanterix Corp
Award(A)Direct3.5K shares at avg. $4.34$15K - May 18, 2026QSI
Quantum-Si Inc
Award(A)DirectStock Option (right to buy)
251.2K shares- - Apr 1, 2026QTRX
Quanterix Corp
Award(A)Direct4.3K shares- - Jan 2, 2026QTRX
Quanterix Corp
Award(A)Direct1.9K shares- - Jan 2, 2026QTRX
Quanterix Corp
Award(A)Direct23.4K shares- - Oct 1, 2025QTRX
Quanterix Corp
Award(A)Direct2.1K shares at avg. $5.54$12K - Jul 8, 2025AKYA
Akoya Biosciences, Inc.
Other(J)Direct28.5K shares- - Jul 8, 2025QTRX
Quanterix Corp
Award(A)Direct24.5K shares- - Jul 8, 2025QTRX
Quanterix Corp
Award(A)Direct4.2K shares- - May 19, 2025QSI
Quantum-Si Inc
Award(A)DirectStock Option (right to buy)
126.1K shares- - Oct 2, 2024AKYA
Akoya Biosciences, Inc.
Award(A)DirectStock Option (right to buy)
45K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 1, 2026 |  QTRX Quanterix Corp | Award(A) | 4,398 | $3.41 | $14,997 | Direct |
| Jul 8, 2026 | QTRX Quanterix Corp | Exercise(M) | 8,073 | - | $0 | Direct |
| Jul 1, 2026 | QTRX Quanterix Corp | Award(A) | 3,456 | $4.34 | $14,999 | Direct |
| May 18, 2026 |  QSI Quantum-Si Inc | Award(A) Stock Option (right to buy) | 251,185 | - | - | Direct |
| Apr 1, 2026 | QTRX Quanterix Corp | Award(A) | 4,310 | - | $0 | Direct |
| Jan 2, 2026 | QTRX Quanterix Corp | Award(A) | 1,944 | - | $0 | Direct |
| Jan 2, 2026 | QTRX Quanterix Corp | Award(A) | 23,372 | - | $0 | Direct |
| Oct 1, 2025 | QTRX Quanterix Corp | Award(A) | 2,084 | $5.54 | $11,545 | Direct |
| Jul 8, 2025 |  AKYA Akoya Biosciences, Inc. | Other(J) | 28,500 | - | - | Direct |
| Jul 8, 2025 | QTRX Quanterix Corp | Award(A) | 24,464 | - | - | Direct |
| Jul 8, 2025 | QTRX Quanterix Corp | Award(A) | 4,189 | - | - | Direct |
| May 19, 2025 | QSI Quantum-Si Inc | Award(A) Stock Option (right to buy) | 126,095 | - | - | Direct |
| Oct 2, 2024 | AKYA Akoya Biosciences, Inc. | Award(A) Stock Option (right to buy) | 44,959 | - | - | Direct |
1-13 of 13 transactions
About Mendel Scott
Mendel Scott (SEC CIK 0001515051) files insider reports with the SEC as Director of Quanterix Corp (QTRX), Director of Quantum-Si Inc (QSI) and Director of Akoya Biosciences, Inc. (AKYA).
Signal8 holds 12 ownership filings by Mendel Scott (1 Form 3, 11 Form 4), filed between Oct 4, 2024 and Oct 2, 2026. Those filings report 13 transactions, from Oct 2, 2024 to Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Mendel Scott's filings is in BILLERICA, MA.
Recent filings by Mendel Scott
- Oct 1, 2026: Grant or award of QTRX shares (Form 4, code A).
- Jul 8, 2026: Option exercise of QTRX shares (Form 4, code M).
- Jul 1, 2026: Grant or award of QTRX shares (Form 4, code A).
- May 18, 2026: Grant or award of QSI derivative securities (Form 4, code A).
- Apr 1, 2026: Grant or award of QTRX shares (Form 4, code A).
Other insiders filing for Quanterix Corp (QTRX)
- Miller Michael Francis, Chief Technology Officer
- Magovcevic-Liebisch Ivana, Director
- DONNELLY WILLIAM P, Director
- Gute James Edward Jr., Chief Commercial Officer
- Elliott Jeffrey Thomas, Director
- Faessler Jason F., Chief Financial Officer